Open AccessBiologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease
Author(s) -
Cristina Bezzio,
Lucienne Pellegrini,
Gianpiero Manes,
Ilaria Arena,
Desirée Picascia,
C. Della Corte,
Massimo Devani,
M. Schettino,
Simone Saibeni
Publication year - 2020
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izaa242
Subject(s) - inflammatory bowel disease , medicine , covid-19 , inflammatory bowel diseases , disease , medline , gastroenterology , intensive care medicine , virology , infectious disease (medical specialty) , outbreak , political science , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom